Corrigendum to “Intracranial hemorrhage after recombinant tissue plasminogen Activator: The competing risks survival analysis” [Interdiscip. Neurosurg. 32 (2023) 101734] (Interdisciplinary Neurosurgery: Advanced Techniques and Case Management (2023) 32, (S2214751923000178), (10.1016/j.inat.2023.101734))

Pengtong W.Aimyong N.Nilanont Y.Mahidol University2026-03-162026-03-162026-01-01Interdisciplinary Neurosurgery Advanced Techniques and Case Management (2026)https://repository.li.mahidol.ac.th/handle/123456789/115722The authors regret the following correction is made on section 2. Materials and methods with underline, …“This study was approved by the Siriraj Institutional Review Board (SIRB) (COA: SI 093/2019, protocol no. 026/2562 (EC4))….” The authors would like to apologise for any inconvenience caused.MedicineCorrigendum to “Intracranial hemorrhage after recombinant tissue plasminogen Activator: The competing risks survival analysis” [Interdiscip. Neurosurg. 32 (2023) 101734] (Interdisciplinary Neurosurgery: Advanced Techniques and Case Management (2023) 32, (S2214751923000178), (10.1016/j.inat.2023.101734))ErratumSCOPUS10.1016/j.inat.2026.1022452-s2.0-10503215275722147519